Dr. Reddy’s launches Ziprasidone Hydrochloride capsules
Dr Reddy’s Laboratories has launched ziprasidone hydrochloride capsules, a bioequivalent generic version of Geodon in the US market on March 2, 2012 following the approval by the United States Food & Drug Administration (US FDA) of Dr Reddy’s ANDA for ziprasidone hydrochloride capsules.
The Geodon brand had US sales of approximately $1.34 billion for the most recent twelve months ending December 2011 according to IMS Health.
Dr Reddy’s ziprasidone hydrochloride capsules in 20 mg, 40 mg, 60 mg and 80 mg strengths are available in 60 count bottle size.